Supernus Pharmaceuticals (SUPN) EBT (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly EBT of -$57.6 million for Q2 2026, down 445.84% year-over-year from $16.7 million in Q2 2025, and down 2911.91% on a QoQ basis from -$1.9 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) EBT (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported EBT for 16 years, with the latest figure at -$57.6 million in Q2 2026.
- EBT for Q2 2026 came in at -$57.6 million, down 445.84% year-over-year; the trailing twelve-month figure through Jun 2026 was -$100.8 million (down 222.74% YoY), and the FY2025 annual result was -$49.0 million, down 150.1% from the prior year.
- EBT eased to -$57.6 million in Q2 2026, from -$1.9 million in the prior quarter.
- Over five years, EBT peaked at $44.9 million in Q3 2024 and troughed at -$58.0 million in Q3 2025.
- A 5-year average of $3.2 million and a median of $9.0 million in 2023 frame the typical range for EBT.
- The widest annual swing landed in 2024, when EBT soared 2564.85%; it then sank 2499.59% in 2025.
- A 5-year view of EBT shows it stood at $35.1 million in 2022, then tumbled by 97.18% to $990000.0 in 2023, then soared by 2564.85% to $26.4 million in 2024, then slumped by 107.25% to -$1.9 million in 2025, then slumped by 2911.91% to -$57.6 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$57.6 million in Q2 2026, -$1.9 million in Q4 2025, and -$58.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.77 Bn | 2.39 Bn | 185.39 Mn | -57.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -57.65 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Sep 30, 2025 | -57.95 Mn |
| Jun 30, 2025 | 16.67 Mn |
| Mar 31, 2025 | -5.83 Mn |
| Dec 31, 2024 | 26.38 Mn |
| Sep 30, 2024 | 44.94 Mn |
| Jun 30, 2024 | 26.30 Mn |
| Mar 31, 2024 | 243,000.00 |
| Dec 31, 2023 | 990,000.00 |
| Sep 30, 2023 | 9.89 Mn |
| Jun 30, 2023 | -17.13 Mn |
| Mar 31, 2023 | 9.02 Mn |
| Dec 31, 2022 | 35.14 Mn |
| Sep 30, 2022 | -444,000.00 |
| Jun 30, 2022 | 11.32 Mn |
| Mar 31, 2022 | 14.72 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 28.96 Mn |
| Jun 30, 2021 | 31.24 Mn |